STACK · Layered protocol · 4 tiers

Skin & Hair.

GHK-Cu is the most clinically studied skin peptide — here are its layers.

Layered · additive + goal-fork

Hook facts

The science, in one line each.

Skin-Glow (GHK-Cu)

GHK-Cu was discovered in 1973 when a researcher noticed that ageing human liver tissue started behaving like young tissue when exposed to a mystery fraction from young blood plasma — and that mystery molecule turned out to be a simple three-amino-acid copper complex your body already makes, that simply declines 60% by age 60.

When to skip it

Read this first.

Melanotan-2 is not appropriate for individuals with a personal or family history of melanoma or skin cancer, as it stimulates melanocyte activity. People with atypical or dysplastic naevi should discuss Melanotan-2 specifically with a physician before use. Individuals with active inflammatory skin conditions should consult a physician before starting BPC-157, as its wound-healing acceleration may alter the course of existing treatments.

Always cleared with your concierge before protocol start.

Why this works

The strongest evidence.

GHK-Cu has been shown to modulate the expression of over 31% of human genes involved in tissue repair and ageing — including approximately 2,000 individual RNA expression signatures — a genomic footprint that surpasses most single compounds studied in anti-ageing medicine. Published RCTs in the Journal of Cosmetics, Dermatological Sciences and Applications demonstrate measurable improvements in facial wrinkle parameters, collagen and elastin production, and MMP/TIMP expression balance in controlled human studies. Blood plasma GHK-Cu levels decline approximately 60% between ages 20 and 60, making targeted replenishment a direct intervention against a well-characterised age-related deficit. GHK-Cu is the strongest scientifically anchored compound in this stack by a significant margin — its evidence base includes multiple controlled clinical trials, not solely mechanistic or preclinical data.

Layered protocol

Choose your tier.

A layered protocol — most tiers add to the last, with a fork or rotation where the data calls for it.

Step 1Additive

Collagen Reset

Skin-Glow (GHK-Cu)

The primary compound for anti-ageing, wrinkle reduction, skin firmness, collagen synthesis, and hair follicle support. T…

GHK-Cu is the headliner of this stack — and for good reason. Published RCTs demonstrate measurable improvements in facial wrinkle parameters, collagen and elastin synthesis, and MMP/TIMP expression balance in controlled human studies. Its genomic footprint — approximately 2,000 RNA expression signatures modulated toward repair and regeneration — surpasses most single peptides studied in anti-ageing medicine. Plasma GHK-Cu levels decline 60% between ages 20 and 60; this tier directly addresses that deficit. Start here. The evidence supports it.

Who it's for

First-time users wanting the single most evidence-backed anti-ageing peptide for skin. The cleanest entry point: one compound, the strongest scientific anchor in the stack, and well-characterised effects across collagen synthesis, wrinkle reduction, and hair follicle support. No additional repair compounds needed to see meaningful results.

What to expect

Early collagen remodelling signals — improved skin texture, reduced dryness, early luminosity shift — by week 3–4. Measurable wrinkle depth reduction and improved skin elasticity by week 8–12. Hair follicle response (improved density) typically expressed by week 8–12 with consistent use.

Step 2Additive

Skin Repair Stack

Skin-Glow (GHK-Cu)

The primary compound for anti-ageing, wrinkle reduction, skin firmness, collagen synthesis, and hair follicle support. T…

BPC-157

Post-procedure recovery (laser, microneedling, surgery), active scarring patterns, or users who want to layer systemic w…

Foundation delivers the collagen and matrix-remodelling signal. Standard adds BPC-157 on top — angiogenesis, collagen deposition, and scar-minimisation at the wound-healing level. The two compounds operate on different layers: GHK-Cu works at the fibroblast and gene-expression level, reshaping the extracellular matrix over weeks; BPC-157 accelerates active repair at wound and procedure sites, reducing scarring and accelerating closure. Particularly valuable for anyone post-microneedling, post-laser, post-surgery, or with established scarring patterns where the collagen signal alone isn't enough.

Who it's for

Users with scarring patterns, post-procedure recovery goals (laser resurfacing, microneedling, surgery), or deeper collagen and wound-healing priorities alongside anti-ageing. BPC-157 adds a wound-healing and scar-minimisation layer that GHK-Cu alone does not provide.

What to expect

BPC-157 adds systemic wound-healing depth and accelerated post-procedure recovery not achievable with GHK-Cu alone. Scarring and post-procedure healing noticeably accelerated by week 4–6. Collagen deposition and fine-line reduction continue on the same GHK-Cu timeline (week 8–12).

Step 3Additive

Full Regenerative

Skin-Glow (GHK-Cu)

The primary compound for anti-ageing, wrinkle reduction, skin firmness, collagen synthesis, and hair follicle support. T…

BPC-157

Post-procedure recovery (laser, microneedling, surgery), active scarring patterns, or users who want to layer systemic w…

TB-500

Users wanting the complete regenerative depth — particularly those with hair regrowth goals or post-procedure cases wher…

The full regenerative stack. GHK-Cu provides the collagen and matrix-remodelling foundation; BPC-157 adds wound-healing depth and scar minimisation; TB-500 extends the signal systemically — angiogenesis, stem cell migration to repair sites, and the tissue-regeneration layer used adjunctively in aesthetic dermatology for hair regrowth and accelerated healing. This is the protocol for users where depth of regeneration matters more than simplicity: post-procedure cases with significant surface area, active hair-loss patterns, or anyone who needs the full vascularisation signal alongside the collagen and wound-healing axes.

Who it's for

Users wanting the complete regenerative dermatology stack — anti-ageing, wound healing, and angiogenic tissue regeneration combined. Particularly relevant for hair regrowth goals or post-procedure cases where systemic depth matters. The Pro tier adds TB-500's angiogenic and stem-cell mobilisation signal on top of the GHK-Cu and BPC-157 base.

What to expect

TB-500's angiogenic effect adds blood vessel formation and systemic tissue regeneration that BPC-157 alone does not produce. Hair follicle response — improved density, visible regrowth — typically expressed by week 8–12. Post-procedure recovery depth is the most comprehensive available in this stack at this tier.

Path DFork

Photo-Protection

Melanotan 2

Users whose primary goal is UV photoprotection or melanin-based pigmentation — a distinct goal axis from collagen anti-a…

Melanotan-2 is a different goal entirely. It's a synthetic α-MSH analogue that activates MC1R and MC4R receptors — driving melanin production and UV photoprotection via the body's own pigmentation mechanism, at an amplified magnitude. The result is genuine UV protection (not a screen — the skin itself becomes more resistant to UV damage) and a melanin-based tan without sun exposure. This is not a next step up from the collagen tiers — it targets pigment, not repair. It also carries a real adverse effect profile: transient nausea is common at the start, hyperpigmentation in existing naevi can occur, and blood pressure effects have been reported. Patient screening matters here — anyone with melanoma history or atypical moles should not use Melanotan-2. Choose this fork with intention, not as a default add-on.

Who it's for

Users whose primary goal is UV photoprotection or melanin-based skin pigmentation — not collagen or anti-ageing. This is a goal-fork, not a tier above Pro. Choose this path if photoprotection or skin tone is the priority; do not add Melanotan-2 to a GHK-Cu protocol expecting anti-ageing synergy — the mechanisms are unrelated.

What to expect

Melanin-based photoprotection typically expressed within 1–2 weeks of Melanotan-2 loading. Pigmentation develops progressively; UV sensitivity reduces in parallel. Adverse effects — nausea, flushing, hyperpigmentation in existing naevi — are most common during loading and typically reduce with maintenance dosing. Monitor existing moles for changes and report anything atypical to your prescriber.

Compound roster

Every compound, briefed.

Each compound in this stack — what it does and where it fits.

FoundationStandardPro

GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex that declines with age — plasma levels fall approximately 60% between ages 20 and 60. Its primary mechanism is regulation of MMP/TIMP balance in the extracellular matrix: it downregulates matrix metalloproteinases responsible for collagen degradation while upregulating tissue inhibitors of metalloproteinases, shifting the net balance from breakdown toward synthesis and remodelling. This drives measurable increases in collagen Type I and III and elastin production. Beyond the extracellular matrix, GHK-Cu modulates approximately 2,000 RNA expression signatures — a genomic footprint documented in peer-reviewed literature and validated in controlled clinical trials on ageing skin. Hair follicle activation is a well-documented secondary effect, making it relevant for scalp and hair density goals alongside skin anti-ageing. Effective both topically and subcutaneously.

Best for · The primary compound for anti-ageing, wrinkle reduction, skin firmness, collagen synthesis, and hair follicle support. The strongest scientific anchor in this stack and the recommended starting point for any skin-focused protocol.

StandardPro

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. In the skin context, its key mechanisms are angiogenesis (new blood vessel formation to supply repair sites), collagen deposition, and local anti-inflammatory signalling that reduces scar tissue formation. It upregulates nitric oxide synthesis and growth factor expression at wound sites, accelerating both epithelial and dermal healing. The framing here is post-procedure and scar-specific — different from its tendon and ligament angle in the Recovery stack. For skin, BPC-157 is particularly relevant following microneedling, laser resurfacing, chemical peels, or surgical procedures where accelerated wound closure and minimised scarring are the priority.

Best for · Post-procedure recovery (laser, microneedling, surgery), active scarring patterns, or users who want to layer systemic wound-healing depth on top of the GHK-Cu collagen foundation.

TB-500 (Thymosin Beta-4 synthetic analogue) is a peptide that promotes systemic tissue mobilisation by upregulating actin polymerisation and cell migration. In dermal and hair contexts, its primary relevance is angiogenic: it promotes new capillary formation to repair sites and facilitates migration of stem cells and progenitor cells to areas of damage. This systemic tissue-regeneration signal extends the stack's reach beyond the local BPC-157 effect — supporting hair follicle regrowth and dermal repair in areas that require new vascularisation rather than just local wound healing.

Best for · Users wanting the complete regenerative depth — particularly those with hair regrowth goals or post-procedure cases where systemic angiogenic support meaningfully extends recovery beyond what GHK-Cu and BPC-157 alone produce.

Pre-mixed TB-500 and BPC-157 in a single vial, combining the systemic angiogenic and stem-cell mobilisation signal of TB-500 with the local wound-healing, collagen-deposition, and scar-minimisation effects of BPC-157. In skin contexts, this combination addresses both the systemic depth (new blood vessel formation, progenitor cell migration) and the local repair layer (collagen deposition, reduced scarring) in a single injection. The convenience formulation for users running both compounds — clinically equivalent to separate vials but reduces injection burden.

Best for · Pro-tier users who want both BPC-157 and TB-500 with minimal preparation, particularly post-procedure or hair regrowth protocols where both wound-healing and angiogenic depth are needed simultaneously.

Melanotan-2 is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that acts as an agonist at MC1R and MC4R receptors. MC1R activation drives eumelanin synthesis in melanocytes — producing skin pigmentation (tanning) that functions as a photoprotective response against UV radiation. The resulting melanin absorbs and dissipates UV energy, offering genuine (not cosmetic) UV protection via the same mechanism the body uses naturally, but at an amplified magnitude. MC4R agonism also produces libido-enhancing effects, which some users seek independently. Its mechanism is entirely distinct from the collagen and repair axis of the other compounds in this stack — Melanotan-2 does not stimulate collagen synthesis, does not modulate MMP/TIMP, and does not contribute to wound healing. Adverse effects include transient nausea (especially at higher doses), facial flushing, hyperpigmentation in pre-existing naevi, potential activation of atypical moles, and modest blood pressure increases. These are real and require informed patient selection.

Best for · Users whose primary goal is UV photoprotection or melanin-based pigmentation — a distinct goal axis from collagen anti-ageing. Not a tier-up from GHK-Cu; a fork into a different objective. Requires careful patient screening for melanoma history and existing atypical naevi.

The science

Peer-reviewed findings.

Key research findings from the compounds in this stack.

Skin-Glow (GHK-Cu)

Genome-wide analysis showed GHK-Cu modulates the expression of over 4,000 human genes — upregulating genes for collagen, antioxidant enzymes, and stem cell markers (p53, integrins), while downregulating inflammation and oncogene pathways.

SOURCE · Pickart & Margolina, Cosmetics (MDPI) 2018; Frontiers in Aging Neuroscience

Skin-Glow (GHK-Cu)

Clinical cosmetic studies confirmed GHK-Cu tightens loose skin, reverses thinning, improves elasticity, increases skin density, reduces fine lines and deep wrinkles, and protects against UV damage — with reproducible results across topical and injectable application forms.

SOURCE · Multiple clinical cosmetic studies (compiled in Pickart review, Biomed Research International 2015)

Protocol

How to run it.

Frequency

GHK-Cu (skin-glow): 2 mg subcutaneous injection 3–5× per week, or 1–3% topical serum applied daily; BPC-157: 250–500 mcg subcutaneous injection once daily; TB-500: 2–5 mg subcutaneous injection twice weekly; Melanotan-2 (Photo-Protection fork): 0.25–1 mg subcutaneous injection 3–5× per week — begin at the low end to assess tolerability

Duration

GHK-Cu: 12–16 weeks to complete a full collagen remodelling cycle; Melanotan-2 loading phase 2–4 weeks, then maintenance dosing with periodic reassessment

Timing

GHK-Cu injectable: any time, consistent daily or alternate-day schedule; topical GHK-Cu: apply to clean skin morning and/or evening; BPC-157: once daily, any time; Melanotan-2: evening injection preferred to reduce nausea during sleep

Cycling

GHK-Cu: continuous use for 12–16 weeks, then reassess; maintenance dosing 2–3× per week long-term is well-tolerated. Melanotan-2: loading phase then maintenance; cycle off periodically to assess baseline pigmentation and monitor any changes in existing naevi

Who it's for

Your profile.

Adults in their 30s, 40s, and 50s experiencing visible signs of skin ageing — loss of firmness, fine lines, uneven texture, reduced radiance — who want a science-backed approach beyond topical skincare. Blood plasma GHK-Cu levels decline approximately 60% between ages 20 and 60; this stack directly addresses that deficit at the cellular level. Core audience: anyone wanting to restore collagen and elastin production rather than mask decline with surface treatments. The Standard and Pro tiers extend the stack to post-procedure recovery (microneedling, laser, surgery) and systemic tissue regeneration including scalp and hair follicle health. The Photo-Protection goal-fork is a distinct path — suited to users whose primary priority is UV photoprotection and melanin-based pigmentation rather than anti-ageing.

Timeline

What to expect.

  1. Week 1–2

    Early improvements in skin hydration and texture as GHK-Cu signals fibroblasts to upregulate glycosaminoglycan production. Some users notice a luminosity shift — improved moisture retention and a subtle 'glow'. BPC-157 (Standard/Pro tiers) begins accelerating healing of any active skin damage. Melanotan-2 users (Photo-Protection fork) will see early melanocyte activation — initial pigmentation changes within the first 1–2 weeks.

  2. Week 6

    Measurable improvements in skin firmness and elasticity as collagen Type I and III synthesis ramps up. Visible reduction in fine lines and improved skin density. Improved tone evenness in photodamaged areas. BPC-157 post-procedure acceleration clearly expressed by this point. TB-500 (Pro tier) begins contributing angiogenic signal — improved blood supply to repair sites. Melanotan-2 photoprotective effects are established, reducing UV sensitivity and burn risk.

  3. Week 12

    Substantial anti-ageing outcomes — controlled clinical studies on GHK-Cu protocols demonstrate improved skin thickness, reduced wrinkle depth, and enhanced dermal density. Skin elasticity 'snap-back' quality returns. Hair follicle response (improved density) typically expressed by week 8–12 with consistent GHK-Cu use. Collagen remodelling continues to improve beyond week 12 with maintained dosing. Melanotan-2 fork: stable, sustained melanin-based pigmentation and comprehensive UV photoprotection.

Stacking notes

How this combines.

This stack has two distinct axes — do not conflate them. Axis one is collagen, elastin, and hair-follicle repair, anchored by GHK-Cu. GHK-Cu is a copper-binding tripeptide that modulates MMP/TIMP balance (extracellular matrix remodelling), stimulates collagen and elastin synthesis, activates hair follicles, and has been shown to modulate approximately 2,000 RNA expression signatures toward a regenerative phenotype — a genomic footprint without parallel among peptides in this catalogue. BPC-157 adds a wound-healing and scar-repair layer on top: angiogenesis, collagen deposition, and local anti-inflammatory signalling — particularly valuable post-procedure or where scarring is a goal. TB-500 (Pro tier) extends the axis further via systemic tissue mobilisation: stem cell migration to dermal repair sites and angiogenic remodelling. Axis two is pigment and UV photoprotection, driven exclusively by Melanotan-2. MT-2 acts on MC1R and MC4R receptors as a synthetic α-MSH analogue, driving melanin production and UV protection by a mechanism entirely separate from the collagen axis. These are not additive tiers — they serve different goals. Users who are primarily anti-ageing should not default to adding MT-2 on top of GHK-Cu; the Photo-Protection tier is a fork, not a step up.